Matthew Hellmann
46PUBLICATIONS
386CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (46)
Sort by Publication Date:
|Apr 18, 2025
Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer.Federica Pecci, Rohit Thummalapalli, Stephanie L Alden
|Nov 25, 2024
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer.Camila Robles-Oteíza, Katherine Hastings, Jungmin Choi
|Jul 22, 2024
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non-Small-Cell Lung Cancer.Arielle Elkrief, Meagan Montesion, Smruthy Sivakumar
|Dec 21, 2023
Objective Analysis and Clinical Significance of the Spatial Tumor-Infiltrating Lymphocyte Patterns in Non-Small Cell Lung Cancer.Miguel Lopez de Rodas, Yvonne Wang, Gang Peng
|Dec 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.Arielle Elkrief, Nicholas R Waters, Natalie Smith
|Jul 24, 2023
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study.Arielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti
Pageof 8
Frequent Collaborators
11 joint publications
Charles M Rudin
7 joint publications
Adam J Schoenfeld
7 joint publications
Jamie E Chaft
7 joint publications
Andrew Plodkowski
6 joint publications
Taha Merghoub
5 joint publications
Jia Luo
5 joint publications
Arielle Elkrief
5 joint publications
Jacklynn V Egger
4 joint publications
Jennifer L Sauter
4 joint publications
Jedd D Wolchok
